Compare LMND & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMND | GRFS |
|---|---|---|
| Founded | 2015 | 1940 |
| Country | United States | Spain |
| Employees | 1282 | 25247 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 5.8B |
| IPO Year | N/A | N/A |
| Metric | LMND | GRFS |
|---|---|---|
| Price | $54.80 | $7.83 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $60.75 | $10.15 |
| AVG Volume (30 Days) | ★ 2.6M | 682.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.93 | $5.33 |
| Revenue Next Year | $32.87 | $6.50 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.31 | $6.19 |
| 52 Week High | $99.90 | $11.14 |
| Indicator | LMND | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 27.72 |
| Support Level | $48.32 | $7.64 |
| Resistance Level | $58.56 | $9.11 |
| Average True Range (ATR) | 3.07 | 0.29 |
| MACD | 0.85 | -0.12 |
| Stochastic Oscillator | 74.47 | 2.99 |
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.